We have been in the process of investigating novel therapies, identifying innovative applications for technology in medicine and developing emerging biomedical technologies.
These efforts exist in collaboration with the UCLA Center for SMART Health, UCLA School of Bioengineering, UCLA Center for Inflammatory Bowel Diseases and several external academic and industry partners. Applications under development include novel drug candidates, mobile technologies and artificial intelligence for gastroenterology and nutrition.
- Limketkai BN, Maas L, Krishna M, Dua A, DeDecker L, Sauk JS, Parian AM. Machine learning-based characterization of longitudinal health care utilization among patients with inflammatory bowel diseases. Inflammatory Bowel Diseases, izad127, July 15, 2023
- Spartz EJ, DeDecker L, Le D, Jalilian L, Limketkai BN. Advances in mobile health for inflammatory bowel disease. Diagnostics (Basel). 2022 Dec 23;13(1):37
- Limketkai BN, Mauldin K, Manitius N, Jalilian L, Salonen BR. The age of artificial intelligence: Use of digital technology in clinical nutrition. Current Surgery Reports. 2021;9(7) 20
- Saiki JP, Andreasson JO, Grimes KV, Frumkin LR, Sanjines E, Davidson MG, Park KT, Limketkai B. Treatment-refractory ulcerative colitis responsive to indigo naturalis. BMJ Open Gastroenterol 2021;8(1)